Zinc-dependent
metalloprotease inhibitors
phosphoramidon,
captopril and a
peptide hydroxamate were studied as potential pretreatment compounds by examining their ability to delay the onset or to prolong the time to 50% block of nerve-elicited muscle twitch tension in the mouse phrenic-nerve diaphragm (in vitro at 36 degrees C) after
botulinum neurotoxin serotypes A and B (
BoNT-A, BoNT-B). Addition of
BoNT-A or BoNT-B (1 x 10(-10) M) produced 50% block of the twitch response at 56 +/- 9 min and 76 +/- 4 min, respectively. Preincubation (45 min) of muscles with
phosphoramidon (0.2 mM) prolonged the time to 50% block by 15 min in BoNT-B-poisoned muscles with no effect on the time-course of
paralysis in
BoNT-A exposed muscles. When the same quantities of
BoNT-A or BoNT-B (equivalent to 1 x 10(-10) M bath concentration) were preincubated for 2 hr with
phosphoramidon (equivalent to 0.2 mM final bath concentration), and the incubation mixture was added to the muscle chamber, the times to 50% block were prolonged by 38 min and 18 min for BoNT-B and
BoNT-A, respectively. Preincubation of diaphragms with
captopril (up to 10 mM) or
peptide hydroxamate (75 microM) failed to antagonize
BoNT-A or BoNT-B-induced neuromuscular block. Among the three
metalloprotease inhibitors examined here, only
phosphoramidon showed a significant protection against both serotypes of BoNT. A search for better inhibitor compounds specifically tailored to match the active site on BoNT molecule deserves attention.